3 Wellness Brand and Medical Device Stocks With a Strong Future Roadmap: Emami, Zydus Wellness and Poly Medicure

Emami Rs 367.25, P/E 21.39. Zydus Wellness Rs 495.80, P/E 83.72. Poly Medicure Rs 1,605.20, P/E 51.87. Closing prices of 8 Oct 2026.

Updated: 9 Oct 2026 • 10:47 am

Posted by:

Quick Answer

Wellness brand and medical device stocks with the clearest long-term roadmaps today include Emami in personal care and wellness brands, Zydus Wellness in nutrition and personal care brands and Poly Medicure in medical devices. FY26 revenue growth was -0.3% at Emami, 45.7% at Zydus Wellness and 13.4% at Poly Medicure. P/E stands at 21.39 for Emami (industry 34.85), 83.72 for Zydus Wellness (industry 34.85) and 51.87 for Poly Medicure (industry 62.79). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company's risks need equal attention.

Wellness brand and medical device stocks give investors exposure to companies that earn from health-focused consumer brands and medical devices. Brand strength, volumes and export demand decide how steady earnings are.

Readers comparing wellness brand and medical device stocks should weigh growth, margins, cash flow and valuation together instead of leaning on any single number.

This list covers three wellness brand and medical device stocks: Emami for personal care and wellness brands, Zydus Wellness for nutrition and personal care brands and Poly Medicure for medical devices. Every figure comes from the latest reported financials and the 8 October 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

Table of Contents

What Are Wellness Brand and Medical Device Stocks?

Wellness brand and medical device stocks are shares of companies that sell health and personal care brands and medical devices. Results depend on brand strength, volumes and export demand, so brand strength and volume growth separate the stronger names.

Wellness Brand and Medical Device Stocks at a Glance

The table compares size, valuation, return on equity and debt for the three wellness brand and medical device stocks as of the 8 Oct 2026 close.

Company	CMP (Rs)	Market Cap (Rs Cr)	P/E	Industry P/E	ROE	Debt to Equity
Emami	367.25	16,041	21.39	34.85	26.51%	0.06
Zydus Wellness	495.80	15,768	83.72	34.85	3.98%	0.55
Poly Medicure	1,605.20	16,231	51.87	62.79	10.37%	0.11

Among healthcare consumer stocks, Zydus Wellness trades at a premium to the industry P/E, while Emami and Poly Medicure trade at a discount.

Why Do Wellness Brand and Medical Device Stocks Have a Strong Roadmap in India?

Wellness brand and medical device stocks have a strong roadmap in India because consumers are spending more on health and personal care and hospitals are using more disposable devices. Three drivers stand out.

Health spending: Households spend more on nutrition, wellness and personal care.
Brand power: Established brands keep repeat sales through seasons.
Device demand: Hospitals use more infusion and vascular devices.

Emami: Personal Care and Wellness Brands Anchor the Roadmap

Emami's roadmap rests on personal care and wellness brands such as Navratna, Zandu and BoroPlus, with a seasonal product mix and strong brands supporting sales.

Revenue grew from Rs 3,287.28 crore in FY22 to Rs 3,864.63 crore in FY26, a 17.6% rise, and FY26 revenue was 0.3% lower than FY25. FY26 net profit fell 3.4% to Rs 775.25 crore. Over four years, net profit fell from Rs 836.66 crore in FY22 to Rs 775.25 crore. In Q1 FY27, revenue grew 14.3% to Rs 1,057.71 crore, and net profit fell 15.4% to Rs 138.94 crore. Operating margin was 27.37% in FY26 and 23.39% in Q1 FY27 against 25.85% a year earlier.

Debt to equity is 0.06 and return on equity is 26.51%. FY26 operating cash flow was Rs 800.53 crore against capital expenditure of Rs 43.32 crore. Emami paid a dividend of Rs 10 per share for FY26, a yield of 2.72%. At a P/E of 21.39 against an industry P/E of 34.85, the stock trades below its industry multiple.

What to watch: The Q1 FY27 operating margin of 23.39% was below the 25.85% of a year earlier, and Q1 FY27 net profit was 15.4% lower than a year earlier.

Zydus Wellness: Nutrition and Personal Care Brands Drive the Pipeline

Zydus Wellness' roadmap rests on nutrition and personal care brands such as Complan, Glucon-D, Sugar Free and Nycil, with seasonal beverage demand and a wider brand portfolio supporting sales.

Revenue grew from Rs 2,019.50 crore in FY22 to Rs 3,967.40 crore in FY26, a 96.5% rise, and FY26 revenue was 45.7% higher than FY25. FY26 net profit fell 43.2% to Rs 197.20 crore. Over four years, net profit fell from Rs 308.87 crore in FY22 to Rs 197.20 crore. In Q1 FY27, revenue grew 66.8% to Rs 1,440.80 crore, and net profit fell 7.0% to Rs 118.90 crore. Operating margin was 12.93% in FY26 and 17.17% in Q1 FY27 against 18.49% a year earlier.

Debt to equity is 0.55 and return on equity is 3.98%. FY26 operating cash flow was Rs 226.40 crore against capital expenditure of Rs 101.70 crore. Zydus Wellness paid a dividend of Rs 1.2 per share for FY26, a yield of 0.24%. At a P/E of 83.72 against an industry P/E of 34.85, the stock trades above its industry multiple.

What to watch: Q1 FY27 net profit was 7.0% lower than a year earlier, and FY26 net profit of Rs 197.20 Cr was lower than the Rs 346.90 Cr of FY25. The P/E of 83.72 sits above the industry P/E of 34.85, so earnings delivery matters for the valuation.

Poly Medicure: Medical Devices Build the Next Leg

Poly Medicure's roadmap rests on medical devices such as infusion sets, needles, catheters and dialysis products sold in India and many export markets, with rising healthcare consumption and export demand supporting growth.

Revenue grew from Rs 960.97 crore in FY22 to Rs 1,995.34 crore in FY26, a 107.6% rise, and FY26 revenue was 13.4% higher than FY25. FY26 net profit fell 5.3% to Rs 320.73 crore. Over four years, net profit rose from Rs 146.51 crore in FY22 to Rs 320.73 crore. In Q1 FY27, revenue grew 25.5% to Rs 558.79 crore, and net profit fell 8.4% to Rs 85.27 crore. Operating margin was 27.65% in FY26 and 30.47% in Q1 FY27 against 36.99% a year earlier.

Debt to equity is 0.11 and return on equity is 10.37%. FY26 operating cash flow was Rs 246.37 crore against capital expenditure of Rs 308.39 crore. Poly Medicure paid a dividend of Rs 3.5 per share for FY26, a yield of 0.22%. At a P/E of 51.87 against an industry P/E of 62.79, the stock trades below its industry multiple.

What to watch: The Q1 FY27 operating margin of 30.47% was below the 36.99% of a year earlier, and Q1 FY27 net profit was 8.4% lower than a year earlier.

Best Wellness Brand and Medical Device Stocks in India: Emami vs Zydus Wellness vs Poly Medicure on Key Financials

Among the best wellness brand and medical device stocks in India, Emami leads on return on equity and the lowest P/E; Zydus Wellness leads on FY26 revenue growth and Q1 FY27 revenue growth; Poly Medicure leads on FY26 operating margin. The table puts the numbers side by side.

Metric	Emami	Zydus Wellness	Poly Medicure
FY26 revenue (Rs Cr)	3,864.63	3,967.40	1,995.34
FY26 revenue growth	-0.3%	45.7%	13.4%
FY26 net profit (Rs Cr)	775.25	197.20	320.73
FY26 net profit growth	-3.4%	-43.2%	-5.3%
FY26 operating profit margin	27.37%	12.93%	27.65%
Q1 FY27 revenue growth (YoY)	14.3%	66.8%	25.5%
Q1 FY27 net profit growth (YoY)	-15.4%	-7.0%	-8.4%
Return on equity	26.51%	3.98%	10.37%
P/E ratio	21.39	83.72	51.87
Debt to equity	0.06	0.55	0.11
Dividend yield	2.72%	0.24%	0.22%
FY26 operating cash flow (Rs Cr)	800.53	226.40	246.37

Consumer healthcare earnings follow brand strength, volumes and export demand, so full-year numbers and quarterly trends together give a better view.

How to Evaluate Wellness Brand and Medical Device Stocks to Buy Before You Invest

A short checklist keeps the research consistent when you screen wellness brand and medical device stocks and shortlist wellness brand and medical device stocks to buy.

Compare each stock's P/E with its industry P/E, which differs by company here.
Check volume growth versus price growth, since volume shows real demand.
Check whether revenue growth is turning into profit growth, not only sales.
Read operating cash flow against capital expenditure to see how growth is funded.
Watch debt to equity and interest cover before sizing a position.
Spread exposure across companies and business lines instead of one demand cycle.

Check the Univest Screener for live data on these wellness brand and medical device stocks

Risks to Consider Before Investing in Wellness Brand and Medical Device Stocks

Valuation: Zydus Wellness trades at 83.72 times earnings against an industry multiple of 34.85.
Quarterly profit: Emami's Q1 FY27 net profit was 15.4% lower than a year earlier.
Annual profit: Emami's FY26 net profit of Rs 775.25 Cr was lower than the Rs 802.74 Cr of FY25.
Seasonal demand: Some products sell more in specific seasons.

Download the Univest iOS App or Univest Android App to track Emami, Zydus Wellness and Poly Medicure live.

Final Take: Which Stock Has the Strongest Roadmap?

These three healthcare consumer stocks cover personal care and wellness brands, nutrition and personal care brands and medical devices. Emami leads on return on equity and the lowest P/E; Zydus Wellness leads on FY26 revenue growth and Q1 FY27 revenue growth; Poly Medicure leads on FY26 operating margin.

Across wellness brand and medical device stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the wellness brand and medical device stocks to buy discussed here.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on Wellness Brand and Medical Device Stocks

Which are the best wellness brand and medical device stocks in India with a strong roadmap?

Ans. Emami, Zydus Wellness and Poly Medicure stand out for their roadmaps in personal care and wellness brands, nutrition and personal care brands and medical devices. FY26 revenue growth was -0.3% at Emami, 45.7% at Zydus Wellness and 13.4% at Poly Medicure, and return on equity ranges from 3.98% to 26.51%.

Is Emami a good stock to buy now?

Ans. Emami has a debt to equity ratio of 0.06, a return on equity of 26.51% and a P/E of 21.39 against an industry P/E of 34.85. Valuation, seasonality and raw material costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.

What is the P/E ratio of Emami, Zydus Wellness and Poly Medicure?

Ans. The P/E ratio is 21.39 for Emami (industry 34.85), 83.72 for Zydus Wellness (industry 34.85) and 51.87 for Poly Medicure (industry 62.79). Only Zydus Wellness trades at or above the industry multiple.

Which of these wellness brand and medical device stocks has the highest return on equity?

Ans. Emami has the highest return on equity at 26.51%, followed by Poly Medicure at 10.37% and Zydus Wellness at 3.98%.

What are the risks of investing in wellness brand and medical device stocks?

Ans. The main risks are valuation, quarterly profit, annual profit and seasonal demand. Zydus Wellness trades at 83.72 times earnings against an industry multiple of 34.85.

How did Emami, Zydus Wellness and Poly Medicure perform in Q1 FY27?

Ans. Emami reported revenue of Rs 1,057.71 crore, up 14.3% year on year, and net profit fell 15.4% to Rs 138.94 crore. Zydus Wellness reported revenue of Rs 1,440.80 crore, up 66.8% year on year, and net profit fell 7.0% to Rs 118.90 crore. Poly Medicure reported revenue of Rs 558.79 crore, up 25.5% year on year, and net profit fell 8.4% to Rs 85.27 crore.

Do wellness brand and medical device stocks pay dividends?

Ans. Yes, all three companies pay dividends. The dividend yield is 2.72% for Emami, 0.24% for Zydus Wellness and 0.22% for Poly Medicure, based on dividends declared for FY26.

How can I invest in wellness brand and medical device stocks in India?

Ans. You can buy wellness brand and medical device stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.